CLOs on the Move

Reckitt Benckiser

www.rb.com

 
We protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. Our products reach millions of people every day, as we fight to improve global access to the highest quality hygiene, wellness and nourishment. We`re a growing community of 40,000+ diverse, talented entrepreneurs, and the driving force behind some of the world`s most loved and trusted brands. Our portfolio includes household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Lysol, Dettol, Harpic, Cillit Bang, Finish and Vanish. Hygiene, Health and Nutrition are the focus areas of our business, and the categories under which our brands ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.rb.com
  • 399 Interpace Parkway P.O. Box 225
    Parsippany, NJ USA 07054
  • Phone: 973.404.2600

Executives

Name Title Contact Details
Pascal Montilus
Chief Supply Chain Officer Profile
Monica Wahba
Assistant General Counsel - Global Business Solutions Profile
Justin Griner
Legal Director NA, Nutrition Profile
Eliane Setton
VP - General Counsel, Compliance Officer, Corporate Secretary, Hygiene Home, North America Profile
Tara Byrne
Associate General Counsel Profile

Similar Companies

Hugh Chatham Memorial Hospital

Hugh Chatham Memorial Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Hugh Chatham Memorial Hospital is based in Elkin, NC. You can find more information on Hugh Chatham Memorial Hospital at www.hughchatham.org

Morristown Manor

Morristown Manor is a Morristown, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Roundtable Healthcare Partners

Roundtable Healthcare Partners is a Lake Forest, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Executive Source International

Executive Source International is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ASCENDIS PHARMA

Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.